Naguy A. Therapeutic use of melatonin in schizophrenia-more than meets the eye!
World J Psychiatry 2022;
12:533-535. [PMID:
35433328 PMCID:
PMC8968506 DOI:
10.5498/wjp.v12.i3.533]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Revised: 11/08/2021] [Accepted: 02/13/2022] [Indexed: 02/06/2023] Open
Abstract
Adjunctive melatonin use in schizophrenia, as supported by a modicum of evidence, has multiple transcending chronobiotic actions, including fixing concurrent sleep problems to bona fide augmentative antipsychotic actions, mitigating the risk of tardive dyskinesias, curbing the drastic metabolic syndrome and ultimately providing neuroprotective actions. Its use is rather an art than science!
Collapse